Unichem Laboratories Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹400.9
- Today's High:
- ₹433.3
- Open Price:
- ₹433.3
- 52W Low:
- ₹265
- 52W High:
- ₹467
- Prev. Close:
- ₹429.25
- Volume:
- 11658
Company Statistics
- Market Cap.:
- ₹17.29 billion
- Book Value:
- 356.504
- Revenue TTM:
- ₹13.07 billion
- Operating Margin TTM:
- -3.31%
- Gross Profit TTM:
- ₹7.74 billion
- Profit Margin:
- -1.58%
- Return on Assets TTM:
- -0.87%
- Return on Equity TTM:
- -0.81%
Company Profile
Unichem Laboratories Limited had its IPO on under the ticker symbol 506690.
The company operates in the Other sector and Other industry. Unichem Laboratories Limited has a staff strength of 0 employees.
Stock update
Shares of Unichem Laboratories Limited opened at ₹433.3 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹400.9 - ₹433.3, and closed at ₹405.25.
This is a -5.59% slip from the previous day's closing price.
A total volume of 11,658 shares were traded at the close of the day’s session.
In the last one week, shares of Unichem Laboratories Limited have slipped by -3%.
Unichem Laboratories Limited's Key Ratios
Unichem Laboratories Limited has a market cap of ₹17.29 billion, indicating a price to book ratio of 0.6456 and a price to sales ratio of 1.3378.
In the last 12-months Unichem Laboratories Limited’s revenue was ₹13.07 billion with a gross profit of ₹7.74 billion and an EBITDA of ₹338.04 million. The EBITDA ratio measures Unichem Laboratories Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Unichem Laboratories Limited’s operating margin was -3.31% while its return on assets stood at -0.87% with a return of equity of -0.81%.
In Q3, Unichem Laboratories Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 7.4%.
Unichem Laboratories Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹-2.934 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Unichem Laboratories Limited’s profitability.
Unichem Laboratories Limited stock is trading at a EV to sales ratio of 0.9813 and a EV to EBITDA ratio of 18.7956. Its price to sales ratio in the trailing 12-months stood at 1.3378.
Unichem Laboratories Limited stock pays annual dividends of ₹4 per share, indicating a yield of 1.72% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹31.93 billion
- Total Liabilities
- ₹6.40 billion
- Operating Cash Flow
- ₹2.03 billion
- Capital Expenditure
- ₹443.16 million
- Dividend Payout Ratio
- 0%
Unichem Laboratories Limited ended 2024 with ₹31.93 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹31.93 billion while shareholder equity stood at ₹24.35 billion.
Unichem Laboratories Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹6.40 billion in other current liabilities, 140812000.00 in common stock, ₹24.21 billion in retained earnings and ₹15.45 million in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹1.89 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹636.49 million.
Unichem Laboratories Limited’s total current assets stands at ₹15.88 billion while long-term investments were ₹0 and short-term investments were ₹32.43 million. Its net receivables were ₹5.89 billion compared to accounts payable of ₹0 and inventory worth ₹6.25 billion.
In 2024, Unichem Laboratories Limited's operating cash flow was ₹2.03 billion while its capital expenditure stood at ₹443.16 million.
Comparatively, Unichem Laboratories Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹405.25
- 52-Week High
- ₹467
- 52-Week Low
- ₹265
- Analyst Target Price
- ₹
Unichem Laboratories Limited stock is currently trading at ₹405.25 per share. It touched a 52-week high of ₹467 and a 52-week low of ₹467. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹399.47 and 200-day moving average was ₹352.71 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5195.4% of the company’s stock are held by insiders while 971.2% are held by institutions.
Frequently Asked Questions About Unichem Laboratories Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. It offers pharma products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients. The company was founded in 1944 and is based in Mumbai, India.